A 2025 systematic review and network meta-analysis of 55 randomized trials (18,876 participants) demonstrated sustained improvements in HbA1c, fasting glucose, body weight, and systolic blood pressure with GLP-1 RAs for up to 104 weeks, although HbA1c and fasting glucose reductions declined slightly (0.36% and 0.47 mmol/L, respectively) after two years [119]
Are there long-term safety risks with Ozempic
Includes: No payment required until approved Includes: No payment required until approved Includes: No payment required until approved Needle-free, compounded GLP-1 options designed for patients who prefer an oral alternative
Supporting this, data from our functional enrichment analysis of the transcriptome revealed notable upregulation of oxidative phosphorylation and the oxidative damage response in hepsin / mice treated with saline (data not shown)
Always consult with a professional to determine the right dosage and protocol for your goals